米力农治疗急性加重期慢性充血性心力衰竭的效果研究  

Effect of milrinone in the treatment of acute exacerbation chronic congestive heart failure

作　　者：王祥锋 Wang Xiangfeng(Department of Cardiology,Yongding Hospital of Suzhou,Jiangsu Province,Jiangsu Suzhou 215200)

机构地区：[1]江苏省苏州永鼎医院心内科

出　　处：《中国社区医师》2020年第3期35-35,37,共2页Chinese Community Doctors

摘　　要：目的:探讨米力农治疗急性加重期慢性充血性心力衰竭的效果。方法:2017年1月-2019年2月收治急性加重期慢性充血性心力衰竭患者60例,随机分为两组各30例。常规治疗组采取常规抗心衰治疗;米力农治疗组采取常规抗心衰联合米力农治疗。比较两组治疗效果。结果:治疗后,米力农治疗组疗效、充血性心力衰竭纠正时间、住院天数、LVEF以及脑钠肽、S100β水平优于常规治疗组,差异有统计学意义(P<0.05)。结论:常规抗心衰联合米力农治疗急性加重期慢性充血性心力衰竭的疗效好,可更好改善LVEF以及脑钠肽、S100β水平。Objective:To explore the effect of milrinone in the treatment of acute exacerbation chronic congestive heart failure.Methods:From January 2017 to February 2019,60 patients with acute exacerbation chronic congestive heart failure were selected and randomly divided into two groups of 30 patients in each.The routine treatment group was treated with routine anti heart failure treatment,the milrinone treatment group was treated with routine anti heart failure combined milrinone.We compared the efficacy of the two groups.Results:After treatment,in the milrinone treatment group,curative effect,correction time of congestive heart failure,hospitalization days,LVEF,brain natriuretic peptide and S100 β levels were superior to the routine treatment group,the difference was statistically significant(P<0.05).Conclusion:The effect of routine anti heart failure combined milrinone in the treatment of acute exacerbation chronic congestive heart failure was better,it can improve the level of LVEF,brain natriuretic peptide and S100 β.

关 键 词：米力农 急性加重期 慢性充血性心力衰竭 

分 类 号：R541.6[医药卫生—心血管疾病]